Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report) crossed below its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $1.39 and traded as low as $1.3130. Organicell Regenerative Medicine shares last traded at $1.46, with a volume of 374 shares trading hands.
Organicell Regenerative Medicine Stock Down 3.2%
The firm’s fifty day moving average price is $1.38 and its 200 day moving average price is $1.72.
About Organicell Regenerative Medicine
Organicell Regenerative Medicine, Inc (OTCMKTS:BPSR) is a biotechnology company focused on regenerative medicine and the development of biologic therapies intended to address inflammation, tissue injury and other medical conditions. The company’s research centers on acellular products derived from human perinatal tissues, including extracellular vesicles and exosomes that may support the body’s natural repair processes.
Organicell’s principal investigational product is Zofin, a non-cellular biologic preparation derived from human amniotic fluid.
Further Reading
- Five stocks we like better than Organicell Regenerative Medicine
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
